TLSI Q1 2026 Earnings EPS Surprises Positively Despite No Revenue Stock Declines Retractable Technologies Q3 2023 Earnings Loss Per Share of 014 Reported Stock Rises Amid Limited Disclosure REVB Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Reports Operating Loss VKTX Q1 2026 Earnings WiderthanExpected Loss in a PreRevenue Stage ARTL Q4 2025 Earnings NarrowerThanExpected Loss Despite Zero Revenue Bluejay Diagnostics BJDX Q4 2023 Earnings DeeperThanExpected Losses as Development Spending Weighs on Results